We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
Cap. Flow
-$256M
Cap. Flow %
-0.25%
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$35.4M
2
P
Everpure Inc
P
+$21M
3
NVDA icon
NVIDIA
NVDA
+$20.7M
4
AMH icon
American Homes 4 Rent
AMH
+$19.3M
5
DAY
Dayforce
DAY
+$19M

Sector Composition

Rank Sector Weight
1 Technology 28.42%
2 Financials 13.09%
3 Healthcare 11.94%
4 Consumer Discretionary 10.95%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XIN
3701
DELISTED
Xinyuan Real Estate
XIN
$1.27K ﹤0.01%
470
XENE icon
3702
Xenon Pharmaceuticals
XENE
$6.12B
$1.25K ﹤0.01%
+29
New +$1.33K
TIL icon
3703
Instil Bio
TIL
$50.3M
$1.23K ﹤0.01%
114
DCBO
3704
Docebo
DCBO
$566M
$1.22K ﹤0.01%
25
CCU
3705
DELISTED
CLEAR CHANNEL COMMUNICTNS INC
CCU
$1.2K ﹤0.01%
+100
New +$1.2K
HYFM icon
3706
Hydrofarm Holdings
HYFM
$7.62M
$1.18K ﹤0.01%
109
BNED icon
3707
Barnes & Noble Education
BNED
$443M
$1.16K ﹤0.01%
16
GROW icon
3708
US Global Investors
GROW
$38.5M
$1.16K ﹤0.01%
417
BRLT icon
3709
Brilliant Earth
BRLT
$21.6M
$1.15K ﹤0.01%
386
SII
3710
Sprott
SII
$3.03B
$1.15K ﹤0.01%
31
-39
-56% -$1.4K
SOND
3711
DELISTED
Sonder
SOND
$1.13K ﹤0.01%
381
QTTB icon
3712
Q32 Bio
QTTB
$464M
$1.11K ﹤0.01%
65
CODX
3713
Co-Diagnostics
CODX
$5.6M
$1.09K ﹤0.01%
32
MHH icon
3714
Mastech Digital
MHH
$93.2M
$1.06K ﹤0.01%
118
PASG icon
3715
Passage Bio
PASG
$14.1M
$1.06K ﹤0.01%
39
MOLN
3716
Molecular Partners
MOLN
$1.04K ﹤0.01%
269
QH
3717
Quhuo Limited Class A Ordinary Shares
QH
$12M
$1.01K ﹤0.01%
19
SCOR icon
3718
Comscore
SCOR
$109M
$1K ﹤0.01%
65
CELU icon
3719
Celularity
CELU
$20.3M
$988 ﹤0.01%
189
RANI icon
3720
Rani Therapeutics
RANI
$89M
$970 ﹤0.01%
312
BNTC icon
3721
Benitec Biopharma
BNTC
$468M
$952 ﹤0.01%
186
EGIO
3722
DELISTED
Edgio, Inc. Common Stock
EGIO
$935 ﹤0.01%
97
-1
-1% -$10
NEUE
3723
DELISTED
NeueHealth
NEUE
$929 ﹤0.01%
+143
New +$1.28K
EVAX
3724
Evaxion A/S
EVAX
$25.9M
$928 ﹤0.01%
58
CRON
3725
Cronos Group
CRON
$1.14B
$926 ﹤0.01%
355
-430
-55% -$922

Similar funds

RhumbLine Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
  • RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
  • RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
  • RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
  • RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
  • RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
  • RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.